Dasiglucagon acetate

Dasiglucagon acetate is a novel glucagon analog for diabetic hypoglycemia therapy. Dasiglucagon acetate has demonstrated established solubility and stability in an aqueous formulation. Pharmacokinetics studies have shown dasiglucagon acetate to exhibit higher absorption and a longer plasma elimination half-life than traditional reconstituted glucagon.

CC(C[C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)[C@H](O)C)=O)CO)=O)CCC(O)=O)=O)NC([C@@H](NC([C@@H](NC([C@H](C(C)C)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(C(C)(NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H]([C@H](O)C)NC([C@@H](NC([C@H]([C@H](O)C)NC(CNC([C@@H](NC([C@@H](NC([C@H](Cc1nc[nH]c1)N)=O)CO)=O)CCC(N)=O)=O)=O)=O)Cc2ccccc2)=O)=O)CO)=O)CC(O)=O)=O)Cc3ccc(O)cc3)=O)CO)=O)CCCCN)=O)Cc4ccc(O)cc4)=O)CC(C)C)=O)CC(O)=O)=O)C)=O)C)=O)CCCNC(N)=N)=O)C)=O)CCC(O)=O)=O)CCC(O)=O)=O)Cc5ccccc5)=O)=O)CCCCN)=O)Cc(c[nH]6)c7c6cccc7)=O)C.CC(O)=O